Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 4, 2019 |
| Target | Core Diagnostics |
| Sector | Life Science |
| Buyer(s) | Canopy Biosciences |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2016 |
| Sector | Life Science |
Canopy Biosciences LLC is a provider of gene editing and gene expression products and services. Canopy's gene-editing portfolio spans easy-to-use CRISPR kits, off-the-shelf cell lines, as well as full-service custom cell line engineering. Canopy Biosciences was founded in 2016 and is based in St. Louis, Missouri.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 2 of 2 |
| State: California | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2019 | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-04-29 |
Zellkraftwerk
Leipzig, Germany Zellkraftwerk GmbH is a manufacturer of ZellScanner™ ONE, device able to analyze more than 100 markers per cell based on the Chipcytometry technology. The device allows for deep insights into formerly unknown cell subpopulations and their state of activation, while its microfluidic chips can be additionally used for sample storage that guarantee biomarker stability for up to 24 months. Zellkraftwerk GmbH was founded in 2014 and is based in Leipzig, Germany. |
Buy | - |
